EFFICACY OF NEUROPROTECTIVE DRUGS IN ACUTE REPERFUSION CARDIOEMBOLIC STROKE

Ходжиева Дилбар Таджиевна, Нурова Зарнигор Хикматовна

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research · 2022-yil

Annotatsiya

Stroke is the leading cause of disability and the second most common cause of death worldwide. Accurate determination of the mechanism of stroke is crucial, because the most effective care and therapy depend on it. Cardioembolic stroke accounts for 14-30% of all cerebral infarcts. In most cases, recurrence of cardioembolic stroke can be prevented with oral anticoagulants. Therefore, early confirmation of the diagnosis of cardioembolic infarction is extremely important for the patient with cerebral infarction to start anticoagulant therapy for adequate secondary prevention.

Maqola ma’lumotlari
MualliflarХоджиева Дилбар Таджиевна, Нурова Зарнигор Хикматовна
JurnalЖурнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research
Nashr sanasi2022-10-13
Jild3
Son4
TilRus

Kalit so‘zlar

острый переод кардиоэмболического инсульта, церебролизин, цитиколин, эдаравон, средняя мозговая артерия, миноциклин, нейропротекторы, period of cardioembolic stroke, cerebrolysin, citicoline, edaravon, middle cerebral artery, minocycline, neuroprotectors, кардиоэмболик инсултнинг ўткир даври, церебролизин, цитиколин, эдаравон, ўрта мия артерияси, миноциклин, нейропротекторлар

Ilmiy soha

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research jurnalidan boshqa maqolalar

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research — barcha maqolalar